Kenya Association of Physicians Scientific Conference

Permanent URI for this collection

Browse

Recent Submissions

Now showing 1 - 10 of 24
  • Item
    Renal Transplant at MTRH
    (Association of Kenya Physicians, 2007) Owiti, M. O. G.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    J.A. 48 yrs male - Diabetic since July 1997, on insulin. Crf & high Bp-2004.urea=57.3, crt=1040. Lt kid-7.27x3.62, rt kid8.51x3.34cm, loss of cmd. Haemodialysis x2 wkly till last two wksx3. While on treatment Bp=150/100, pulse78/min. on Adalat 20mg b.d,lasix 80mg od, captopril 25mg b.d,ca-sandoz i.o.d, recormon 2000i.u x2wkly, venofer 100 wkly, ranitidine150 mgo.d. N.C. 17 yrs female - Facial puff, head ache,oliguria, epigastric and bil loin Painsx3/52. 03.08.2004. Post herbal use. Abortion –pph, 07.06.04, post abortal psychosis. Bp220/110mmhg, hb=7.6g/dl, Op=600mls, ip=1.5l.
  • Item
    Health Care Today Good Business Bad Medicine
    (Association of Kenya Physicians, 2007) Aluoch, J. A.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    HEALTH CARE TODAY • POLITICAL INFLUENCE. • EXPANDING SERVICES • QUALITY OF CARE. • PRIVATE CARE Vs PUBLIC SERVICE.
  • Item
    Slowing Disease Progression in Type 2 Diabetes: Latest Advances
    (Association of Kenya Physicians, 2007) Otieno, C. F.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Background: Largest head-to-head, double-blind study of metformin, glyburide and rosiglitazone (N = 4,360). Primary objective: To compare the durability of glycemic control using rosiglitazone versus metformin or glyburide as initial monotherapy in patients with recently diagnosed type 2 diabetes. Design: Double-blind, randomized, controlled trial. Inclusion criteria: Type 2 diabetes ≤ 3 years, drug-naive, male and female, aged 30–75 years, FPG 126–180 mg/dl (7–10 mmol/l). Exclusion criteria: Previous use of glucose-lowering therapy, women of child-bearing potential, significant hepatic disease, renal impairment, unstable or severe angina, known CHF (NYHA Class I–IV), uncontrolled hypertension. Treatment duration: Treatment period: 4 to 6 years. Median duration of treatment: 4 years (rosiglitazone and metformin); 3.3 years (glyburide). Interventions: Rosiglitazone, metformin, glyburide.
  • Item
    Dr. Abinya's Hodgkin's lymphoma study
    (Association of Kenya Physicians, 2007) Abwao, H. O.; Kiarie, G.W.; Othieno-Abinya, N. A.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Inferior outcome of poor prognostic phenotype non-Hodgkin’s lymphoma treatment among HIV positive patients compared with HIV negative counterparts in the HAART era.
  • Item
    DD of Arthritis
    (Association of Kenya Physicians, 2007) Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Patient with Musculo-skeletal Complaints -Summary 1.Soft Tissue Rheumatism or Arthritis 2.Arthritis –Monoarticular-Crystals, Gout-Infective –acute –G+ve –ve-Chronic –Koch'sPolyarticular-:-(Asymmetrical)SSA -Reiter's, Reactive AS Psoriasis(Symetrical):-RA, SLE, DM. PM, Scleroderma APS, Vasculitis 3.Extraarticular features… 4.Laboratory, Imaging workup : DIAGNOSIS
  • Item
    Management of Arthritis
    (Association of Kenya Physicians, 2007) Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
  • Item
    Disparities in Health Care: Challenges to Physicians
    (Association of Kenya Physicians, 2007) Okelo, G. B. A.; Otieno, L. S.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Many developing countries, including Kenya, face many challenges in health care some of which are outlined below: 1.1Relatively High fertility Rates 1.2 High mortality from preventable diseases 1.3Changing life style such as increasing tobacco consumption and increase in non-communicable diseases 1.4New and re-emerging diseases especially viral diseases 1.5Declining life expectancy 1.6Inadequate and poorly focused and/or targeted goals in disease control 1.7Civil unrest with its implications for health services 1.8Huge burdens of infectious diseases such as HIV/AIDS and tuberculosis 1.9Increasing burdens of non-communicable diseases such as Heart diseases, Cancer [such as prostate cancer, metabolic disorders like diabetes 10.0Slow pace in embracing new technology 11.0A steady rise in the socially disadvantaged groups i.e. women, children and the disabled populations whose access to reasonable health care is very limited. 12.0 Low immunization cover rate.
  • Item
    Disparities of Health Care: Challenge to Physicians
    (Association of Kenya Physicians, 2007) Nyikal, James; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Challenges to the health sector: Finance and financial flows. Rapid growth of infrastructure. Human resource. Emerging diseases. Coordination. Legal framework. Poverty. Challenges to the physician: Health reforms. Leadership role and head of team. Role model. Cost of care and poverty. Ethics in compromised social environment. CPD. Curative care/disease prevention and health promotion. Perpetual dilemma.
  • Item
    Chemotherapy for HIV associated Kaposi's sarcoma
    (Association of Kenya Physicians, 2007) Busakhala, N.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    HIV associated Kaposi’s sarcoma is a malignant, multifocal systemic disease that originates from the vascular endothelium. In contrast to the classical KS found in older men, in whom the tumors usually occur on the lower legs and feet, HIV-associated KS does not have a preferential pattern of localization.
  • Item
    Acute Myeloid Leukemia: The Aga Khan Experience
    (Association of Kenya Physicians, 2007) Ngunga, Mzee; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    AML is characterized by an increase in the number of myeloid cells in the marrow and an arrest in their maturation.